What causes behavioral side effects in popular weight loss drugs?
GLP1R gene variants link to cardiometabolic traits and behavioral changes, but findings suggest behavioral effects of GLP1RA are indirect Study: ...
Tag: GLP-1
Why do people with obesity, but without diabetes, start taking semaglutide?
Factors such as sex, type of insurance plan, and the use of common medications influenced whether individuals with obesity but ...
Benefits and risks of popular weight-loss drugs revealed
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...
How gut microbes and hormones shape your sweet tooth
Researchers discover a gut-microbe-driven pathway involving pantothenate and GLP-1 that could revolutionize sugar consumption management and metabolic health strategies. Study: ...
Nearly half of weight loss participants reduced alcohol use after starting anti-obesity medication
Anti-obesity medications linked to reduced alcohol use, possibly due to effects on cravings and reward systems, with behavioral strategies also ...
Squid-inspired technology could replace needles for medications and vaccines
Using jet propulsion inspired by squid, researchers demonstrate a microjet system that delivers medications directly into tissues, matching the effectiveness ...
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
Diabetes medication shows promise in reducing alcohol use
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity
The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. ...
Semaglutide improves heart health and reduces weight in obese patients, but with side effects
Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% in overweight ...
